department of health and human services

HHS secretary rips Big Pharma in policy speech

Vowing to put American patients first, US Health and Human Services Secretary Alex Azar on Monday blasted the pharmaceutical industry for not doing enough to bring down drug prices and announced what he called "historic action": a proposal requiring drug manufacturers to include the list price of any drug paid for by Medicare or Medicaid in television ads.

Trump administration reviewing fetal tissue research

The Trump administration is opening "a comprehensive review of all research involving fetal tissue" and canceling a contract that conservative lawmakers said supported "research using the body parts of children whose lives have been violently ended by abortion."

Trump admin shifts $260M to pay for immigrant child costs

The Trump administration is planning to shift more than $260 million to cover the rising cost and strain of housing thousands of undocumented immigrant children in their custody -- including millions of dollars from programs like cancer research and HIV/AIDS prevention.

Views of ICE split by partisan divide

About as many Americans view Immigration and Customs Enforcement favorably as those who view it unfavorably, according to a new Pew Research poll released Tuesday.

Despite separations, very few young children handed to DHHS

Though the potential separation of very young children from their parents as a result of the administration's "zero-tolerance" border policy has drawn concern across the country, new data released by the government show very few such children have been impacted.

Jeff Sessions: Migrant children are 'well cared for'

Attorney General Jeff Sessions asserted in an op-ed published late Tuesday that migrant children who are held by the Department of Health and Human Services, including those who are separated from their parents, are "well cared for."

Trump pick to lead HHS to face Senate committee

President Donald Trump's nominee to lead the Department of Health and Human Services, Alex Azar, will appear before a Senate Health Committee panel Wednesday, where he'll likely face tough questions about his ties to the pharmaceutical industry.